Eficiencia de la cirugía refractiva con láser in situ keratomileusis (LASIK) frente al uso de lentes en pacientes con ametropía
No Thumbnail Available
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
Se realizó un estudio con el objetivo de evaluar la eficiencia del tratamiento de
ametropía, comparando la cirugía refractiva con láser in situ keratomileusis (LASIK)
frente al uso de lentes y lentes de contacto, mediante un análisis de costo-utilidad. Se
determinó la utilidad en AVAC (Años de Vida Ajustados a Calidad de vida) mediante
la aplicación del cuestionario Quality of Life Impact of Refractive Correction (QIRC)
a una muestra de 150 pacientes, entre 18 y 40 años, de los cuales 50 usaban lentes, 50
lentes de contacto y 50 fueron operados con Lasik, los costos se calcularon desde la
perspectiva del paciente. El costo del tratamiento con cirugía refractiva fue de S/ 3 650
y su utilidad de 9.47 AVAC, en un horizonte temporal de 11.5 años, siendo la razón
costo-utilidad de 385.47, mientras que para el tratamiento con lentes fue de 455.13 y
para lentes de contacto 1357.14. Se concluye que el tratamiento con cirugía refractiva
es más eficiente.
A study was conducted with the aim of evaluating the efficiency of ametropia treatment, comparing refractive surgery with Laser in Situ Keratomileusis(LASIK) against the use of lenses and contact lenses, using a cost-utility analysis. The utility in QALYs (Quality Adjusted Life Years) was determined by applying the Quality of Life Impact of Refractive Correction (QIRC) questionnaire to a sample of 150 patients, between 18 and 40 years old, of which 50 used lenses, 50 contact lenses and 50 were operated on with Lasik, costs were calculated from the patient's perspective. The cost of refractive surgery treatment was S/ 3 650 and its usefulness of 9.47 AVAC, over a time horizon of 11.5 years, being the cost-utility reason of 385.47, while for lens treatment it was 455.13 and for contact lenses 1357.14. Refractive surgery treatment is found to be more efficient.
A study was conducted with the aim of evaluating the efficiency of ametropia treatment, comparing refractive surgery with Laser in Situ Keratomileusis(LASIK) against the use of lenses and contact lenses, using a cost-utility analysis. The utility in QALYs (Quality Adjusted Life Years) was determined by applying the Quality of Life Impact of Refractive Correction (QIRC) questionnaire to a sample of 150 patients, between 18 and 40 years old, of which 50 used lenses, 50 contact lenses and 50 were operated on with Lasik, costs were calculated from the patient's perspective. The cost of refractive surgery treatment was S/ 3 650 and its usefulness of 9.47 AVAC, over a time horizon of 11.5 years, being the cost-utility reason of 385.47, while for lens treatment it was 455.13 and for contact lenses 1357.14. Refractive surgery treatment is found to be more efficient.
Description
Keywords
Costo-utilidad, AVAC, Ametropía